CliffBio
small molecule

LONHALA MAGNAIR KIT

GLYCOPYRROLATE

Loss of exclusivityDecember 2036latest FDA-listed patent expiry
CompanySumitomo Pharma America →View the full company profile on CliffBio

Drug detail

Brand nameLONHALA MAGNAIR KIT
Active ingredientGLYCOPYRROLATE
Strength25MCG/ML
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalDecember 2017
Marketing statusDISCN

Listed patents

PatentExpiresType
10744277December 2036product
10688518November 2036product
10376661September 2035product
9604018May 2033product
9168556September 2032product
9789270October 2030product
10940110February 2029product
9265900December 2028product
11278683August 2026product

More from Sumitomo Pharma America

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LONHALA MAGNAIR KIT patent cliff — loss of exclusivity December 2036 | CliffBio